ArticleDrugs & aging2025

Efficacy and Safety of Dupilumab in the Treatment of Refractory Atopic Dermatitis in Older Adults: A Retrospective, Single-Center Study.

Renhui Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.